Clinical Trial Update: Evaluation of Effectiveness and Safety of Paliperidone Extended Release in Patients With Schizoaffective Disorder. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effectiveness and safety of Paliperidone Extended Release in schizoaffective disorder has completed, with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizoaffective Disorder, Psychotic Disorder | Phase 3 | Status: COMPLETED | Results posted: 2009-07-28